Celebrating GeriPal’s 200th with Leaders in Geriatrics and Palliative Care
December 30, 2021
It’s GeriPal’s 200th episode. Yup, we started the podcast in 2016 and over the years we have grown from basically…
Geriatric Oncology: Podcast with Melisa Wong and Louise Walter
December 16, 2021
Geriatric Oncology has arrived. Yes, Louise Walter has been leading the fight to improve cancer screening in older adults for…
Geriatric Anesthesia: Podcast with Mark Neuman, Liz Whitlock, and Cindy Hsu
December 10, 2021
Geriatric anesthesia is a thing. The average age of people getting surgery is increasing. Anesthesiologists and surgeons feel that with…
Burnout and Resiliency: A Podcast with Janet Bull and Arif Kamal
December 2, 2021
The great resignation is upon us. One in five health-care workers has left their job since the pandemic started. Geriatrics…
Spiritual Care in Palliative Care: A Podcast with Allison Kestenbaum, Katy Hyman, and Paul Galchutt
November 24, 2021
I don’t consider myself spiritual. For some in palliative care, this would be considered heresy as we are told “everyone…
Every deep drawn breath: Podcast with Wes Ely
November 18, 2021
Though “breath” is in the title of Wes Ely’s book (and his song choice by the Police), relationships are its…
The Messiness of Medical Decision Making in Advanced Illness: A Podcast with James Tulsky
November 11, 2021
Anyone who cares for individuals with serious illness must live in a messy space where tough conversations about treatment decisions…
Reducing Prolonged Admissions: Podcast with Kenny Lam, Jessica Eng, Sarah Hooper, and Anne Fabiny
November 4, 2021
“The secret sauce of the Transitions, Referral and Coordination (TRAC) team was including a lawyer.” This is brilliant and will…
Meaningful Activities: Podcast with Anna Oh and Theresa Allison
October 28, 2021
Most studies in geriatrics have used metrics such as survival time or disability in activities of daily living as their…
“Real world” eligibility for aducanumab: A Podcast with Tim Anderson and Marco Canevelli
October 21, 2021
The FDA label for the amyloid antibody aducanumab (Aduhelm) started off exceedingly broad, basically including anyone with Alzheimer’s disease, but…